Tommy Huppert and medical marijuana
Tommy Huppert’s Cannatrek journey continues to expand and grow as does the herbal product that has recently gone mainstream. Henry Greener talks with him.
Tommy Huppert
More research, especially by Israel’s pioneer scientist Professor Raphael Meshoulam, who this week celebrates his 90th birthday, and a boundless passion is gaining worldwide recognition in his 40-year quest to develop the health benefits of medical cannabis.
With the competent assistance of Head of R&D Emily Rigby in Queensland, Cannatrek is making inroads with their Seed to Patient Model, creating superior quality control, stable supply chains and lowest-cost production distribution methods to find markets, supply the product and expand the promotion of the fact that medical cannabis overcomes the bad press that marijuana has unfortunately suffered for way too long!
